A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine
NCT ID: NCT03004222
Last Updated: 2018-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
137 participants
INTERVENTIONAL
2015-07-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration
NCT03927326
Postoperative Pain Control in Children Undergoing Laparoscopic Appendectomy: Peripheral Nerve Block Versus Local Anesthetic
NCT01662401
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
NCT04032327
A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery
NCT03304444
Transversus Abdominis Plane Catheter: a Study of Method
NCT01395043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local anesthetic (Bupivicaine)
The experimental arm intervention is 75 subjects will receive the study agent (20 mL of 0.5% bupivacaine) to be sprayed at the cecum after the appendix has been removed and all planned irrigation and aspiration has occurred
Bupivacaine
20 ml of 0.5% Bupivacaine
Placebo 20 ml
75 subjects will be treated with normal saline/placebo to be sprayed at the cecum after the appendix has been removed and all planned irrigation and aspiration has occurred
Placebos
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
20 ml of 0.5% Bupivacaine
Placebos
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laparoscopic appendectomy at Metro Health Hospital
Exclusion Criteria
* Suspected or known malignant disease
* Patients with known allergies to the local anesthetic
* Utilizes opioid pain medicine for a chronic condition
* Elective laparoscopic appendectomy
* Known allergy or contraindication to ketorolac
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Metro Health, Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karlin Sevensma, DO
Role: PRINCIPAL_INVESTIGATOR
Metro Health Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Metro Health Hospital
Wyoming, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Appendectomy Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.